On 2025-05-20, Neuphoria Therapeutics Inc. (NEUP) announced earnings per share of $6.55 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.47.

The next expected annoucement date for quarterly earnings is 2025-09-29, with an average estimated earnings per share of $-1.26 for the fiscal quarter ending 2025-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.